Correction: In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning
Naunyn Schmiedebergs Arch Pharmacol
.
2024 Apr;397(4):2525.
doi: 10.1007/s00210-023-02849-z.
Authors
Amin Aliabadi
1
,
Mohammad Reza Haghshenas
2
,
Razie Kiani
2
,
Omid Koohi-Hosseinabadi
3
,
Azar Purkhosrow
1
,
Fatema Pirsalami
1
,
Mohammad Reza Panjehshahin
4
5
,
Nasrollah Erfani
6
7
Affiliations
1
Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
2
Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
3
Central Research Laboratory, Shiraz University of Medical Sciences, Shiraz, Iran.
4
Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. panjeshm@sums.ac.ir.
5
Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. panjeshm@sums.ac.ir.
6
Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. erfanin@sums.ac.ir.
7
Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. erfanin@sums.ac.ir.
PMID:
37987797
DOI:
10.1007/s00210-023-02849-z
No abstract available
Publication types
Published Erratum